Pompe disease: new developments in an old lysosomal storage disorder NK Meena, N Raben Biomolecules 10 (9), 1339, 2020 | 95 | 2020 |
MiT/TFE family of transcription factors: an evolutionary perspective M La Spina, PS Contreras, A Rissone, NK Meena, E Jeong, JA Martina Frontiers in cell and developmental biology 8, 609683, 2021 | 85 | 2021 |
Association of TLR5 gene polymorphisms in ulcerative colitis patients of north India and their role in cytokine homeostasis NK Meena, V Ahuja, K Meena, J Paul PLoS One 10 (3), e0120697, 2015 | 63 | 2015 |
TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis NK Meena, R Verma, N Verma, V Ahuja, J Paul Journal of Clinical Gastroenterology 47 (9), 773-780, 2013 | 46 | 2013 |
Enzyme replacement therapy can reverse pathogenic cascade in Pompe disease NK Meena, E Ralston, N Raben, R Puertollano Molecular Therapy-Methods & Clinical Development 18, 199-214, 2020 | 40 | 2020 |
Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs R Ranjha, NK Meena, A Singh, V Ahuja, J Paul PLoS One 12 (3), e0173447, 2017 | 23 | 2017 |
Role of bromelain as herbal anti-inflammatory compound using in vitro and in vivo model of colitis N Verma, NK Meena, I Majumdar, J Paul J. Autoimmune Dis 3, 1-8, 2017 | 16 | 2017 |
Pros and cons of different ways to address dysfunctional autophagy in Pompe disease JA Lim, NK Meena, N Raben Annals of translational medicine 7 (13), 2019 | 14 | 2019 |
Nutritional co-therapy with 1, 3-butanediol and multi-ingredient antioxidants enhances autophagic clearance in Pompe disease MI Nilsson, M Crozier, A Di Carlo, D Xhuti, K Manta, LJ Roik, AL Bujak, ... Molecular Genetics and Metabolism 137 (1-2), 228-240, 2022 | 9 | 2022 |
Chemoenzymatic glycan-selective remodeling of a therapeutic lysosomal enzyme with high-affinity M6P-glycan ligands. Enzyme substrate specificity is the name of the game X Zhang, H Liu, N Meena, C Li, G Zong, N Raben, R Puertollano, ... Chemical science 12 (37), 12451-12462, 2021 | 9 | 2021 |
AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice NK Meena, D Randazzo, N Raben, R Puertollano JCI insight 8 (16), 2023 | 6 | 2023 |
mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activity NK Meena, SP Pattanayak, Y Ben‐Nun, S Benhamron, S Kumar, ... Immunology 155 (4), 505-518, 2018 | 4 | 2018 |
Intravital imaging of muscle damage and response to therapy in a model of Pompe disease NK Meena, Y Ng, D Randazzo, R Weigert, R Puertollano, N Raben Clinical and Translational Medicine 14 (3), 2024 | 3 | 2024 |
Failure of Autophagy in Pompe Disease H Do, NK Meena, N Raben Biomolecules 14 (5), 573, 2024 | 2 | 2024 |
Assessment of Gene Therapy Treatment in the Pompe Disease Canine Model MK Pope, K Coleman, M Wichman, D Cloutier, C Cousins, LA Mueller, ... MOLECULAR THERAPY 30 (4), 2-3, 2022 | 1 | 2022 |
Skeletal muscle abnormalities in Pompe disease can be reversed by enzyme replacement therapy N Raben, NK Meena, R Puertollano Molecular Genetics and Metabolism 129 (2), S133-S134, 2020 | | 2020 |
Evaluating potential drivers in the pathogenesis of Ulcerative Colitis J Paul, S Valmiki, R Ranjha, I Majumdar, S Aggarwal, R Kumari, ... JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 34, 246-246, 2019 | | 2019 |
Correction: Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs R Ranjha, NK Meena, A Singh, V Ahuja, J Paul Plos one 12 (9), e0184701, 2017 | | 2017 |
Role of Bromelain as Herbal Anti-Inflammatory Compound Using N Verma, NK Meena, I Majumdar, J Paul Vitro, 2017 | | 2017 |
Role of TLR4 polymorphism in modulation of cytokine expression in inflammatory bowel disease patients J Paul, NK Meena, V Ahuja JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27, 162-162, 2012 | | 2012 |